Literature DB >> 19541734

Evaluation of individual skeletal muscle activity by glucose uptake during pedaling exercise at different workloads using positron emission tomography.

Yuichi Gondoh1, Manabu Tashiro, Masatoshi Itoh, Mohammad M Masud, Hiroomi Sensui, Shoichi Watanuki, Kenji Ishii, Hiroaki Takekura, Ryoichi Nagatomi, Toshihiko Fujimoto.   

Abstract

Skeletal muscle glucose uptake closely reflects muscle activity at exercise intensity levels <55% of maximal oxygen consumption (VO2max). Our purpose was to evaluate individual skeletal muscle activity from glucose uptake in humans during pedaling exercise at different workloads by using [18F]fluorodeoxyglucose (FDG) and positron emission tomography (PET). Twenty healthy male subjects were divided into two groups (7 exercise subjects and 13 control subjects). Exercise subjects were studied during 35 min of pedaling exercise at 40 and 55% VO2max exercise intensities. FDG was injected 10 min after the start of exercise or after 20 min of rest. PET scanning of the whole body was conducted after completion of the exercise or rest period. In exercise subjects, mean FDG uptake [standardized uptake ratio (SUR)] of the iliacus muscle and muscles of the anterior part of the thigh was significantly greater than uptake in muscles of control subjects. At 55% VO2max exercise, SURs of the iliacus muscle and thigh muscles, except for the rectus femoris, increased significantly compared with SURs at 40% VO2max exercise. Our results are the first to clarify that the iliacus muscle, as well as the muscles of the anterior thigh, is the prime muscle used during pedaling exercise. In addition, the iliacus muscle and all muscles in the thigh, except for the rectus femoris, contribute when the workload of the pedaling exercise increases from 40 to 55% VO2max.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541734     DOI: 10.1152/japplphysiol.90821.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

1.  Noninvasive evaluation of fat-carbohydrate metabolic switching in heart and contracting skeletal muscle.

Authors:  Timothy R DeGrado; Mukesh K Pandey; Anthony P Belanger; Falguni Basuli; Aditya Bansal; Shuyan Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-04       Impact factor: 4.310

2.  Metabolic and cardiovascular responses during voluntary pedaling exercise with electrical muscle stimulation.

Authors:  Kohei Watanabe; Yoshiki Taniguchi; Toshio Moritani
Journal:  Eur J Appl Physiol       Date:  2014-05-28       Impact factor: 3.078

3.  Regional Variation in Skeletal Muscle and Adipose Tissue FDG Uptake Using PET/CT and Their Relation to BMI.

Authors:  Marcus D Goncalves; Judith Green-McKenzie; Abass Alavi; Drew A Torigian
Journal:  Acad Radiol       Date:  2017-05-24       Impact factor: 3.173

4.  Experimental peripheral arterial disease: new insights into muscle glucose uptake, macrophage, and T-cell polarization during early and late stages.

Authors:  Maxime Pellegrin; Karima Bouzourène; Carole Poitry-Yamate; Vladimir Mlynarik; François Feihl; Jean-François Aubert; Rolf Gruetter; Lucia Mazzolai
Journal:  Physiol Rep       Date:  2014-02-25

5.  Effects of 16-week high-intensity interval training using upper and lower body ergometers on aerobic fitness and morphological changes in healthy men: a preliminary study.

Authors:  Yusuke Osawa; Koichiro Azuma; Shogo Tabata; Fuminori Katsukawa; Hiroyuki Ishida; Yuko Oguma; Toshihide Kawai; Hiroshi Itoh; Shigeo Okuda; Hideo Matsumoto
Journal:  Open Access J Sports Med       Date:  2014-11-04

6.  Evaluation of skeletal muscle activity during foot training exercises using positron emission tomography.

Authors:  Tomoyuki Kanayama; Junsuke Nakase; Takafumi Mochizuki; Kazuki Asai; Rikuto Yoshimizu; Mitsuhiro Kimura; Seigo Kinuya; Hiroyuki Tsuchiya
Journal:  Sci Rep       Date:  2022-04-30       Impact factor: 4.996

7.  Increasing exercise intensity reduces heterogeneity of glucose uptake in human skeletal muscles.

Authors:  Ilkka Heinonen; Sergey V Nesterov; Jukka Kemppainen; Toshihiko Fujimoto; Juhani Knuuti; Kari K Kalliokoski
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.